iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference

Read Press Release

Latest Financial Results

Q3 2017

Quarterly Results

Mar 31, 2017
Further recent Filings may be viewed in SEC Filings.

Stock Information

iBio Inc. NYSE MKT: IBIO
Price Loading...
Change Loading...
Market Cap Loading...
Volume Loading...

Company Overview

iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.

The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.

View Profile